Zoster Eye Disease Study: Rationale and Design
Conclusions:
ZEDS aims to provide scientific evidence on whether suppressive valacyclovir treatment improves outcomes in HZO and should become the standard of care.
Source: Cornea - Category: Opthalmology Tags: Clinical Science Source Type: research
More News: Clinical Trials | Coronavirus | Covid Vaccine | COVID-19 | Herpes | Opthalmology | Pregnancy | Science | Shingles (Herpes Zoster) Vaccine | Study | Vaccines | Valtrex | Varicella-Zoster Virus Vaccine